I always respond positively because maybe they just don’t know or lack knowledge about my skin condition.” Farah admitted ...

A recent study identified three clinically distinct vitiligo profiles on the basis of Vitiligo Patient Priority Outcomes (ViPPO) responses from real-world patient data. Classes with more severe ...

Overactivity of the JAK signalling pathway is believed to drive inflammation involved in the development and progression of vitiligo. New 52-week results from a dose-ranging phase 2b study of ...

Vitiligo and albinism may appear similar ... essentially slowing any progression of the disease.

Light therapy is a common treatment that exposes your skin to a type of ultraviolet light that can help stop or slow the progression of active vitiligo and restore your natural skin color.

At week 24, the ritlecitinib plus nbUVB group saw a higher facial vitiligo severity change from baseline vs. the ritlecitinib-monotherapy group. Similar reductions were seen in body vitiligo severity.

SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types ...

Begur & Partners has advised Colossa Ventures LLP on its equity investment in Ahammune Biosciences Private Limited. The ...

Clarifying that vitiligo is not a contagious disease, Dr Lee said vitiligo cases in Malaysia are at a manageable level. “So far, the progression of vitiligo in Malaysia has remained stable. Thanks to ...